Humacyte, Inc. (HUMA) Reports In-Line Q4 EPS

Humacyte, Inc. (NASDAQ: HUMA) reported Q4 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $500 thousand versus the consensus estimate of $1.35 million.

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
• High-Trend International Group reports BDI rise and revenue growth
• Versigent Ltd. (VGNT) PT Raised to $54 at Argus